Abbonarsi

Surgical management of proximal femoral metastasis: Fixation or hip replacement? A 309 case series - 23/09/20

Doi : 10.1016/j.otsr.2020.05.007 
Pierre Meynard a, , Arthur Seguineau a, Pierre Laumonerie b, Thierry Fabre a, Deborah Foltran b, Lucas Niglis c, Jules Descamps d, Charlie Bouthors e, Marie Lebaron f, Christophe Szymanski g, Fréderic Sailhan d, Paul Bonnevialle b
the

members of the SoFCOTh

a Centre hospitalier universitaire de Bordeaux, place Amélie Raba-Léon, 33076 Bordeaux cedex, France 
b Département universitaire d’orthopédie traumatologie, hôpital Pierre-Paul-Riquet, place Baylac, 31052 Toulouse cedex, France 
c Service d’orthopédie traumatologie, hôpital de Hautepierre, avenue Molière, 67200 Strasbourg, France 
d Service d’orthopédie, hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France 
e Service de chirurgie orthopédique et traumatologie et du Rachis, hôpital Kremlin-Bicêtre, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France 
f Service de chirurgie orthopédique et traumatologie, hôpital Nord, chemin des Bourrely, 13015 Marseille, France 
g Service de chirurgie orthopédique et traumatologie, hôpital Salengro, avenue du Professeur-Emile-Laine, 59037 Lille, France 
h Société française de chirurgie orthopédique et traumatologique (SoFCOT), 56, rue Boissonade, 75014 Paris, France 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Introduction

The proximal femur is the most frequent operative site for metastasis, but there is no consensus between internal fixation and hip replacement. The present multicenter retrospective observational study sought: (1) to compare early clinical results between internal fixation and hip replacement for proximal femoral metastasis (PFM), and (2) to assess events affecting survival.

Hypothesis

The study hypothesis was that internal fixation and hip replacement give comparable clinical results, operative site complications rates and survival.

Material and methods

The series comprised 309 cases, 10 of which were bilateral, in 182 females and 117 males, with a mean age of 67.2±11.5 years and 62.5±13.2 years, respectively. Primaries were mainly breast (118; 38.2%), lung (85; 25.5%) or kidney (40; 12.9%). PFM was revelatory in 114 cases (36.9%). There was visceral involvement in 142 patients (46%), multiple peripheral bone involvement in 212 (68.6%), and spinal involvement in 134 (43.4%). There were 124 pathologic fractures (40%), 51 of which were revelatory. Metastases were cervicocephalic in 135 cases (43.7%), metaphyseal in 166 (53.7%) and both in 8 (2.6%). PFM was osteolytic in 90% of cases, managed by hip replacement in 161 cases and internal fixation in 148 (12 screwed plates, 136 nails). Seventy-seven patients had postoperative radiation therapy.

Results

After hip replacement (n=144), walking was normal in 35 cases (24.3%), impaired but unassisted in 53 (36.8%), with 1 forearm crutch in 24 (16.6%), 2 crutches or a frame in 26 (18%), and impossible in 6 (4.1%). After nailing (n=125), results were respectively 38 (30.4%), 47 (37.6%), 15 (12%), 18 (14.4) and 7 (5.6%). Recovery of normal walking capacity did not significantly differ according to technique (p=0.162); nor did pain or function. Recovery of normal walking capacity was better after preventive surgery (p<0.001). Perioperative complications comprised: 10 cases of severe blood loss, 7 pulmonary embolisms, 6 digestive hemorrhages, and 5 lung infections. Secondarily, there were 11 infections (7 after hip replacement, 2 after nailing, 2 after plate fixation), 7 progressive osteolyses and 5 fractures. Complications rates were significantly higher with plate fixation, with no difference between nailing and hip replacement. Survival did not significantly differ between hip replacement (12 months [95% CI: 7–19]), nailing (7 months [95% CI: 6–11]) and plate fixation (16 months [95% CI: 6-not calculable]).

Conclusions

Clinical results and survival were comparable between hip replacement and nailing, confirming the study hypothesis, in agreement with the literature. Each technique has its indications. Patients with severely impaired walking capacity benefited greatly from surgery. The importance of preventive surgery was highlighted.

Level of evidence

IV, retrospective study.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Proximal femoral metastasis, Pathological fracture, Total hip arthroplasty, Trochanterocephalic locking nail


Mappa


© 2020  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 106 - N° 6

P. 1013-1023 - ottobre 2020 Ritorno al numero
Articolo precedente Articolo precedente
  • High rate of fracture in long-bone metastasis: Proposal for an improved Mirels predictive score
  • Vincent Crenn, Christophe Carlier, François Gouin, Fréderic Sailhan, Paul Bonnevialle, members of the So.F.C.O.T.
| Articolo seguente Articolo seguente
  • Surgical treatment of peri-acetabular metastatic disease: Retrospective, multicentre study of 91 THA cases
  • Pierre Lavignac, Jules Prieur, Thierry Fabre, Jules Descamps, Lucas Niglis, Christophe Carlier, Charlie Bouthors, Thomas Baron-Trocellier, Fréderic Sailhan, Paul Bonnevialle, Members of the S.O.F.C.O.T.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.